Faeth Therapeutics, Inc. (FTH) vs Solid Biosciences Inc. (SLDB)
A side-by-side comparison of Faeth Therapeutics, Inc. and Solid Biosciences Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
FTH
Faeth Therapeutics, Inc.
$26.89HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
SLDB
Solid Biosciences Inc.
$6.92HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — FTH vs SLDB
growth of $100 · dividends reinvested · last 6yFTH -92.8% (-35.5%/yr)SLDB -93.2% (-36.2%/yr)FTH compounded faster over this window
FTH SLDB
FTH vs SLDB: by the numbers
- •FTH is the larger company ($693M vs $681M market cap).
Metrics side by side
Valuation
| Metric | FTH | SLDB |
|---|---|---|
| P/B ratio | 4.01 | 1.82 |
Profitability
| Metric | FTH | SLDB |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -113.05% | -55.36% |
| ROIC | -110.62% | -54.12% |
Growth (annualized)
| Metric | FTH | SLDB |
|---|---|---|
| Total return CAGR (5Y) | -31.75% | -27.50% |
Frequently asked
- How have FTH and SLDB total returns compared?
- Over the past 5 years, FTH delivered -31.75% and SLDB delivered -27.50% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.